Skip to main content

Table 4 Left ventricular parameters of cardiac magnetic resonance at baseline and 6 months after transplantation

From: Kidney transplantation is associated with reduced myocardial fibrosis. A cardiovascular magnetic resonance study with native T1 mapping

 

Baseline

(n = 44)

6 months

(n = 44)

p

Ejection Fraction (%)

64 ± 12

67 ± 10

0.07a

EDV (ml)

155 ± 43

152 ± 35

0.61a

ESV (ml)

52 [38–69]

50 [39–63]

0.49b

SV (ml)

96 ± 21

100 ± 20

0.27a

LVM (g)

154 ± 40

152 ± 35

0.76a

EDVi (mL/m2)

88 ± 23

85 ± 19

0.29a

ESVi (mL/m2)

30 [21–40]

28 [22–36]

0.28b

SVi (mL/m2)

55 ± 12

56 ± 11

0.42a

LVMi (g/m2)

87 ± 20

85 ± 16

0.36a

IS (mm)

12.9 ± 3.3

12.7 ± 3.2

0.71a

LVPW (mm)

10.2 ± 2.2

9.6 ± 1.8

0.07a

LVED (mm)

53 ± 7

52 ± 7

0.21a

LVES (mm)

34 ± 9

33 ± 6

0.20a

  1. BSA body surface area, EDV end-diastolic volume, EDVi end-diastolic volume indexed to BSA, ESV end-systolic volume, ESVi, end-systolic volume index to BSA, LVM left ventricular mass, LVMi left ventricular mass indexed to BSA, SV systolic volume, SVi systolic volume index to BSA, IS interventricular septum, LVPW left ventricular posterior wall, LVED left ventricular end-diastolic diameter, LVES left ventricular end-systolic diameter
  2. Continuous variables expressed as mean and standard deviation (mean ± standard deviation) or median and 25 and 75% percentiles (median [25th and 75th percentile])
  3. apaired t-test; bWilcoxon test